Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A pharmacist unpacks medications at the mobile clinic pharmacy. Through mobile clinics, MSF provides medical services to local populations. Photograph by Tadeu Andre
Press release
Press release |
14 March 2023
Intellectual property and trade
United KingdomIndiaEuropean Union

News Update: EU-India FTA negotiations could have negative impact on access to medicines

4 min
Zara Ahmat, 20, with her baby, Aba Abdulaziz, 1, just vaccinated against measles, Chad, 2019. Photograph by Juan Haro
Press release
Press release |
13 February 2023
Vaccines

New Gavi CEO must prioritise catch-up vaccination and increase inclusive engagement

2 min
Yusufa Adam, 5 years, received treatment for noma in the Sokoto hospital. Photograph by Ghada Safaan
Press release
Press release |
26 January 2023
Tropical & neglected diseases

MSF calls for increased global investment ahead of World NTD Day

6 min
A bottle with bedaquiline. Photo credit: MSF/Alexandra Sadokova
Press release
Press release |
16 January 2023
Tuberculosis
India

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline

4 min
Medical cooler box for the transportation of specimens (blood/sputum) from the point of specimen collection to the laboratory, used for the TB-PRACTECAL clinical trial. Clinical laboratory specimens must be transported at proper temperatures in order to preserve the viability and integrity of the specimen. Photograph by Alexandra Sadokova
Press release
Press release |
22 December 2022
Tuberculosis

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis  

MSF nurse Oleksandr Vovkogon observes Vitalii Gorbachov, 56, take his DR-TB pills at his home in Chudniv village, Zhytomyr region, Ukraine, 2021. Photo credit: Oksana Parafeniuk/MSF
Press release
Press release |
15 December 2022
Tuberculosis

MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis

3 min
Aisha Diabate 30 years (background) arrived at MSF’s specialised AIDS unit in Donka University Hospital with the husband of her sister who is a doctor from Coleah health centre in Conakry. Photograph by Albert Masias
Press release
Press release |
29 November 2022
HIV/AIDS

Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available

5 min
Prachi, an MSF nurse, performs a pre-infusion procedure for Chetan, who lives with DR-TB. Prem Hessenkamp
Press release
Press release |
08 November 2022
Tuberculosis

New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk

6 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury